We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Public Citizen Faults FDA’s Use of Advisory Committees
Public Citizen Faults FDA’s Use of Advisory Committees
January 3, 2007
The FDA is failing to use its advisory committee system properly in reviewing new drug applications (NDAs), the advocacy group Public Citizen writes.